Clinical Trial Update: Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease [Phase 2]

View source ↗

Summary

Amgen conducted a Phase 2 trial to evaluate the safety and activity of an oral medication for moderate-to-severe Crohn's disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Amgen investigational oral medication

Snippet

Sponsor: Amgen | Conditions: Crohn Disease | Phase 2 | Status: COMPLETED